Own report: New vaccines are coming in the market. Whose trial run is over. And the health community is happy with the result. The name Novovax vaccine. The organization has brought its effectiveness publicly. He is 90 percent perfect. The company claims that the Novovax vaccine is effective enough to control corona.

Yesterday (Monday) the report of the trial run was brought to the fore. A total of 29,960 people participated in the trial. This means that the vaccine is applied to this number of people. This vaccine is 100% effective in the body of those who have not been able to show too much force in the body. But on average, the effectiveness of this vaccine is a little over 90 percent.

Read more: Covid UpdateDaily Corona Infection in 60,000 Boundaries, 2,626 Dead

The vaccine was developed by a Maryland company. It is learned that an application for approval for emergency use will be made in early July. The company is ready to make 1 crore vaccines every month. They have also promised to make 1.5 crore vaccines every month by the end of the year.

Read more: Sputnik V in Delhi from June 15 at the price fixed by the Center

NEW DATA RELEASENovavax # COVID19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial https://t.co/lIOiQXxDtD pic.twitter.com/4ePHxDpziZ

– Novavax (ovNovavax) June 14, 2021

India’s best institute, NovoVax, is said to be in charge of developing the vaccine. Covishield, Sputnik V as well as NovoVax vaccine NVX-CoV2373 will make Adar Punawalar Serum. Now just waiting for the green signal.

(Zee 24 Ghanta App : Country, World, State, Kolkata, Entertainment, Sports, Lifestyle Health, Technology Read Latest News Zee 24 Ghanta App)